Establishing an Evaluation Scale for the Perception of Quality of Life Related to Relapsing-Remitting Forms of Multiple Sclerosis and Feasibility Study

被引:4
作者
Baroin, A. [1 ,2 ]
Mokadym, H. [2 ]
Chopard, G. [1 ,2 ]
Lavier, A. [1 ,4 ]
Berger, E. [1 ]
Rumbach, L. [1 ,3 ,4 ]
Rude, N. [2 ]
机构
[1] Besancon Univ Hosp, Dept Neurol, FR-25030 Besancon, France
[2] Univ Franche Comte, Lab Neurosci, EA 481, Besancon, France
[3] Univ Strasbourg, Lab Imagery & Cognit Neurosci, UMR 7237, Strasbourg, France
[4] Besancon Univ Hosp, Clin Invest Ctr Technol Innovat, INSERM, CIC IT 808, FR-25030 Besancon, France
关键词
multiple sclerosis; health evaluation scale; relapse; subjective measures; quality of life; DISABILITY STATUS SCALE; DIAGNOSTIC-CRITERIA; SELF-QUESTIONNAIRE; VALIDATION; PERSPECTIVE; IMPACT; TIME;
D O I
10.3109/00207454.2011.613549
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Relapses are particularly stressful for patients with multiple sclerosis (MS). The impact of relapses on the quality of life (QoL) of patients has been described in the literature. Several QoL scales have already been validated for MS. However, none of them focuses specifically on how patients perceive relapse periods. The objective of this research was to establish a self-questionnaire to evaluate QoL related to MS and relapses: the PERSEPP scale. This scale is based on individual semidirective interviews with patients with a relapsing-remitting form of MS, health workers, and focus groups. The thematic content analysis of these interviews allowed us to obtain 574 items related to various dimensions of QoL. After selecting items in several stages, we drew up the PERSEPP scale with 37 items and five additional modules. A preliminary feasibility study was conducted with 40 patients to assess the PERSEPP scale. The feasibility study showed a good acceptability and a good understanding of the items of the PERSEPP scale. This article deals with the selection of items and the acceptability study. Psychometric validation of this scale, involving 305 patients, is currently in progress in various hospitals in France.
引用
收藏
页码:9 / 16
页数:8
相关论文
共 50 条
[41]   A randomized study of natalizumab dosing regimens for relapsing-remitting multiple sclerosis [J].
Trojano, Maria ;
Ramio-Torrenta, Lluis ;
Grimaldi, Luigi M. E. ;
Lubetzki, Catherine ;
Schippling, Sven ;
Evans, Karleyton C. ;
Ren, Zheng ;
Muralidharan, Kumar Kandadi ;
Licata, Stephanie ;
Gafson, Arie R. .
MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (14) :2240-2253
[42]   Albumin and Protein Oxidation are Predictors that Differentiate Relapsing-Remitting from Progressive Clinical Forms of Multiple Sclerosis [J].
Oliveira, Sayonara R. ;
Kallaur, Ana Paula ;
Reiche, Edna M. V. ;
Kaimen-Maciel, Damacio R. ;
Panis, Carolina ;
Lozovoy, Marcell Alysson B. ;
Morimoto, Helena K. ;
Maes, Michael ;
Dichi, Isaias ;
Colado Simao, Andrea Name .
MOLECULAR NEUROBIOLOGY, 2017, 54 (04) :2961-2968
[43]   Longitudinal Study of Cognitive Phenotypes in Patients with Relapsing-Remitting Multiple Sclerosis [J].
Sousa, Claudia ;
Franca, Marcia ;
Jacques, Teresa ;
Sa, Maria Jose ;
Alves, Rui A. .
ARCHIVES OF CLINICAL NEUROPSYCHOLOGY, 2025, 40 (05) :909-922
[44]   Cerebrospinal fluid isoprostanes are not related to inflammatory activity in relapsing-remitting multiple sclerosis [J].
Greco, A ;
Minghetti, L ;
Puopolo, M ;
Cannoni, S ;
Romano, S ;
Pozzilli, C ;
Levi, G .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2004, 224 (1-2) :23-27
[45]   Effect of alemtuzumab on fatigue, quality of life, and patient/ caregiver-reported outcomes in relapsing-remitting multiple sclerosis-A real-world evidence study [J].
Frederiksen, Jette Lautrup ;
Massacesi, Luca ;
Nielsen, Helle Hvilsted ;
Rini, Augusto ;
Baldi, Eleonora ;
Mirabella, Massimiliano ;
Antonella, Falzone Francesca Maria ;
Lush, Giacomo ;
Paolicelli, Damiano ;
Kant, Matthias ;
Salemi, Giuseppe ;
Aguglia, Umberto ;
Comi, Cristoforo ;
De Riz, Milena ;
Barcella, Valeria ;
Flemmen, Heidi o. ;
Protti, Alessandra ;
Farbu, Elisabeth ;
van Exel, Job ;
Torkildsen, Oivind .
MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2025, 93
[46]   Corpus callosal diffusivity predicts motor impairment in relapsing-remitting multiple sclerosis: A TBSS and tractography study [J].
Kern, Kyle C. ;
Sarcona, Joseph ;
Montag, Michael ;
Giesser, Barbara S. ;
Sicotte, Nancy L. .
NEUROIMAGE, 2011, 55 (03) :1169-1177
[47]   Uric acid in relapsing-remitting multiple sclerosis: a 2-year longitudinal study [J].
Moccia, Marcello ;
Lanzillo, Roberta ;
Costabile, Teresa ;
Russo, Cinzia ;
Carotenuto, Antonio ;
Sasso, Gabriella ;
Postiglione, Emanuela ;
Picione, Carla De Luca ;
Vastola, Michele ;
Maniscalco, Giorgia Teresa ;
Palladino, Raffaele ;
Morra, Vincenzo Brescia .
JOURNAL OF NEUROLOGY, 2015, 262 (04) :961-967
[48]   Cut-off evaluation of intrathecal oligoclonal bands of IgM in relapsing-remitting multiple sclerosis; a retrospective study [J].
Hvaring, Charlotte ;
Alawad, Noor ;
Salvesen, Oyvind ;
Hovdal, Harald ;
White, Linda R. ;
Boullerne, Anne I. .
MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2022, 68
[49]   Clinical and patient determinants of changing therapy in relapsing-remitting multiple sclerosis (SWITCH study) [J].
Patti, Francesco ;
Chisari, Clara Grazia ;
D'Amico, Emanuele ;
Annovazzi, Pietro ;
Banfi, Paola ;
Bergamaschi, Roberto ;
Clerici, Raffaella ;
Conti, Marta Zaffira ;
Cortese, Antonio ;
Fantozzi, Roberta ;
Fischetti, Mariano ;
Frigo, Maura ;
Gatto, Maurizia ;
Immovilli, Paolo ;
Leoni, Stefania ;
Malucchi, Simona ;
Maniscalco, Giorgia ;
Marfia, Girolama Alessandra ;
Paolicelli, Damiano ;
Perini, Paola ;
Serrati, Carlo ;
Sola, Patrizia ;
Totaro, Rocco ;
Turano, Gabriella ;
Valentino, Paola ;
Zaffaroni, Mauro ;
Zuliani, Cristina ;
Centonze, Diego .
MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2020, 42
[50]   Alemtuzumab improves quality-of-life outcomes compared with subcutaneous interferon beta-1a in patients with active relapsing-remitting multiple sclerosis [J].
Arroyo Gonzalez, Rafael ;
Kita, Mariko ;
Crayton, Heidi ;
Havrdova, Eva ;
Margolin, David H. ;
Lake, Stephen L. ;
Giovannoni, Gavin .
MULTIPLE SCLEROSIS JOURNAL, 2017, 23 (10) :1367-1376